Margins on Watch: Can Radico Sustain Blowout Profitability into H2?
Q1's 76% profit surge and record 20.7% EBITDA margin reset expectations hard. Street watches if premiumization momentum and operational leverage hold in Q2, as valuations price in sustained excellence.
The Setup: Margin Durability in Focus
Radico Khaitan opened FY27 with a blowout—consolidated PAT jumped ~76% YoY to ₹230 Cr on gross revenue of ₹5,868 Cr (up 10.4% YoY), but the real story was margin architecture. EBITDA reached a record 20.7% (up 536 bps YoY), gross margin climbed to 49.1%, and the Prestige & Above segment (higher-margin spirits) surged 36% YoY. Magic Moments vodka—the flagship—grew 43% with 60%+ market dominance. Q1 was not a one-time pop; it was the execution of a premiumization thesis. Q2 will test whether the Street's thesis holds: can Radico sustain elevated margins and volume growth as the quarter typically carries monsoon-season headwinds?
~₹1,700–₹1,750 Cr
tracking Q1's ~12% YoY growth run-rate; on-plan if Prestige & Above momentum and Magic Moments hold
~19–21%
Q1's 20.7% was record; sustainability is the question—commodity costs, excise shifts, and product mix will move the needle
~₹220–₹250 Cr
if margin structure holds and revenue grows on plan, low-teens% net profit growth vs Q1 is plausible; upside if P&A accelerates further
~30%+ growth expected
management guided 25%+ for full FY27; Q2 momentum from UK airports (Sep launch), new flavours (Aam Panna Vodka, Aug), and summer base should support
A strong Q2 print would show revenue growth at 10%+ on net-of-excise basis, EBITDA margin ≥19%, and continued P&A segment volume acceleration. Gross margin staying 48%+ signals premiumization is real, not temporary. A weak print would see EBITDA margin compress >200 bps from Q1 (commodities, excise normalization, mix dilution) or P&A growth slip below 20%—signalling the margin cycle may be peaking and Street's 25% FY27 target is at risk.
On Track with Guidance?
Management raised the Prestige & Above volume growth target to 25%+ for full-year FY27 (from 20%), and guided for continued premiumization across portfolio—domestic and export. The UK airport presence (Rampur, Sangam luxury whisky in four major hubs as of late Sep) and new product launches (Aam Panna Vodka, Aug; flavoured moonshine variants) are execution flags supporting that raise. Q1's margin beat (+536 bps EBITDA) was driven by product mix (P&A at higher ASPs), operational leverage, and likely some one-time tailwinds (lower input costs, excise favorability). The debate is whether 20%+ EBITDA is structural or cyclical. If Q2 sustains >19% and P&A volume growth stays 30%+, the thesis holds. If either cracks, the market will reprice expectations lower.
Since Last Quarter: The Event Scan
1 · UK Airport Expansion (Sep 28) — Growth Signal
Radico launched luxury whisky brands (Rampur, Sangam) across Heathrow, Gatwick, Manchester, Birmingham—first Indian spirits player in all four. This validates international premiumization strategy and opens high-margin export channel. Watch for Q2 commentary on order intake and timing of revenue recognition.
2 · New Product Launches (Aug) — Portfolio Breadth
Magic Moments Aam Panna Vodka (flavoured) launched as part of 'Flavours of India' sub-brand. Part of innovation rhythm to maintain Magic Moments 43% YoY growth from Q1. Low risk; extends within core brand.
3 · ESG Ratings (Oct, Aug) — Governance & Compliance
NSE Sustainability rated Radico 69/100 (Oct 16); CRISIL ESG rated 58 (Aug 11); Niche Ninety Nine rated 62 (Sep 18). Routine updates; all in mid-range bands. No material governance issues flagged.
4 · Management Appointments (Jul 28) — Ops Strength
Sudhir Upadhyay appointed Chief Sales Officer, Kunal Madan Chief Marketing Officer. Mid-level executive moves; signals investment in sales and brand management. Routine.
5 · Auditor Re-Appointment (Aug 7) — No Red Flags
Walker Chandiok & Co re-appointed for second 5-year term at AGM. Continuity; no audit concerns.
What to Watch on October 27
1 · EBITDA Margin Integrity
Does EBITDA margin stay ≥19%? If it compresses to <18%, cyclical tailwinds (lower input costs, excise mix) are fading. Watch gross margin (should be 48%+) and OpEx as a % of revenue. Management commentary on commodity inflation and excise changes is critical.
2 · Prestige & Above Momentum
Volume growth in P&A segment—watch if it stays 30%+. Management raised FY27 target to 25%; if Q2 shows 25–30% growth, it's tracking well. If <20%, the acceleration may be peaking. Also watch ASP (average selling price) trajectory—premiumization only works if prices stick.
3 · FY27 Guidance Reaffirm or Raise
Will management reaffirm 25%+ P&A growth, or does Q2 evidence demand a trim? Any commentary on export ramp (UK airports, other geographies) timing and margin accretion? Guidance changes will reprrice valuation risk fast.
Radico Khaitan's Q2 report is not about growth—it's about margin durability and scale. Q1's blowout (76% profit jump, record 20.7% EBITDA) reset the valuation frame, and the Street has priced in sustained excellence at 60x FY28E. The test: can premiumization and operational leverage persist into H2, or was Q1 the peak of the cycle? Revenue in-line with 10%+ growth and EBITDA ≥19% would validate the thesis and likely hold the stock in a ₹4,500–₹5,100 range. A margin miss or P&A slowdown would invite sharp repricing lower. Watch the gross margin, P&A volume narrative, and full-year guidance reaffirm most closely.
Radico Khaitan Q2 FY27: consolidated PAT up 66% YoY to ₹232 Cr as margins hold near 21%
PAT +66.48% YoY · revenue +10.4% · margins expanding · inline vs street
₹5,582.71 Cr
+10.4% YoY
₹232.35 Cr
+66.48% YoY
4.16%
+1.4pp YoY
₹17.34
Radico Khaitan's Q2 FY27 (quarter ended September 30, 2026) consolidated results show profit growth decisively outpacing revenue: consolidated PAT rose 66.5% YoY to ₹232.3 Cr (from ₹139.6 Cr) on revenue from operations of ₹5,582.7 Cr, up 10.4% YoY. Sequentially, revenue dipped 4.9% versus Q1 FY27's ₹5,867.7 Cr — a seasonal pattern typical for alcobev names moving from the summer-heavy Q1 into the monsoon-affected Q2 — while PAT still edged up 1.2% QoQ, holding near Q1's ₹229.6 Cr. Consolidated is the primary basis here; standalone PAT of ₹230.9 Cr is within 1% of the consolidated number, so the two tell the same story this quarter.
Q2 FY-2027 vs prior quarters
Profitability held up because the margin didn't erode with the softer top line. Stripping excise duty (₹3,837.6 Cr) out of gross revenue gives net revenue of ₹1,745.1 Cr, and EBITDA — PBT before JV share and exceptional items (₹307.7 Cr) plus finance costs (₹11.4 Cr) and D&A (₹43.2 Cr) — works out to ₹362.3 Cr, a margin of roughly 20.8%. That's essentially flat with Q1's reported 20.7% "record" margin, meaning the margin gave nothing back sequentially despite the revenue dip. No exceptional items appear in either the current or year-ago quarter column, standalone or consolidated, so both the YoY and QoQ growth rates are clean, organic comparisons — no one-off adjustment is needed this quarter.
The stock went into the print at ₹4,299.9, down 4% over the past month of trading.
For context: this is the second-highest quarterly PAT of the last 6 quarters; PAT has now risen for 5 consecutive quarters.
What the summary numbers don't show
Consolidated basic EPS ₹17.34 vs ₹10.43 year-ago and ₹17.15 last quarter
FY27 P&A portfolio >25% volume growth (raised from 20%); EBITDA margin ~20% sustained; debt-free by Q2 FY27; luxury segment 25% value growth on track (₹475 Cr base).
— This quarter: missed
Against the pre-result preview — which flagged a ₹1,700-1,750 Cr net-of-excise revenue band, 19-21% EBITDA margin and ₹220-250 Cr consolidated PAT as the on-plan bar — the quarter lands inline, printing near the top of the net-revenue band and mid-to-upper range on margin and PAT; sell-side coverage (ICICI Securities, Motilal Oswal, Jefferies, Investec, Systematix), uniformly rated BUY on a sustained-premiumization thesis with targets of ₹4,500-5,100, gets no reason here to revisit those calls. Against management's own August concall guidance, the ~20% EBITDA margin target is met, but "debt-free by Q2 FY27" is not: standalone borrowings stand at ₹247.1 Cr (down from ₹313.3 Cr at March 2026) against cash and bank balances of ₹71.7 Cr, leaving the company still net-debt positive. The filing carries no segment disclosure (single-segment company under Ind-AS 108), so the P&A volume-growth (>25% target) and luxury-segment (25% value growth) guidance lines can't be checked from this statement alone. The quarter's other board-level developments — UK airport retail expansion (September 28) and the Magic Moments Aam Panna Vodka launch (August 20) — are portfolio and distribution-breadth moves that don't show up directly in this P&L.
W1
Net debt payoff pace — standalone borrowings ₹247.1 Cr against the 'debt-free by Q2 FY27' target already missed; watch Q3 reduction
W2
EBITDA margin durability — net-revenue margin held ~20.8% this quarter (vs 20.7% in Q1); confirm it holds into H2 as volume mix shifts
W3
P&A (>25% volume growth) and luxury segment (25% value growth) guidance — unverifiable from this single-segment filing; watch for concall disclosure